Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can radiofrequency waves unfreeze a stiff shoulder?

NCT ID NCT07788287

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial tests whether adding TECAR therapy—a device that delivers gentle radiofrequency energy to warm deep shoulder tissues—to standard stretching exercises helps people with frozen shoulder (adhesive capsulitis) move their shoulder more easily. About 60 adults aged 40 to 65 with stage 2 or 3 frozen shoulder will be split into two groups: one gets stretching alone, the other gets TECAR plus stretching. Researchers will measure changes in shoulder range of motion, pain, and daily function to see if the added therapy makes a meaningful difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transfer of Energy Capacitive and Resistive (TECAR) therapy, a device-based treatment using radiofrequency energy to heat deep tissues, combined with stretching exercises.
What this could lead to
If effective, TECAR therapy could become a standard addition to stretching for frozen shoulder, helping people regain movement and reduce pain without surgery.
What could go wrong
This is a small, early-stage trial, and results may not apply to everyone. TECAR therapy is generally safe but may cause discomfort or skin irritation, and its benefit over stretching alone is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients of both genders with primary adhesive capsulitis. * Patients aged between 40-65. * Pain duration of three months or more. * Range of motion loss of greater than 25% in at least 2 planes and passive external rotation loss that is greater than 50% of the uninvolved shoulder or less than 30° of external rotation. Exclusion Criteria: * Bilateral adhesive capsulitis, * Systemic diseases such as rheumatoid arthritis, * Malignancies, * Heart diseases * Infections * Coagulation disorders * Full rotator cuff tear * History of recent shoulder surgery * Neurological problems involving the upper extremity * Shoulder joint osteoarthritis * Upper extremity fractures * Cervical radiculopathy * Impaired sensation * Having a heart pacemaker * Pregnancy * Physiotherapy treatment in the previous 6 weeks

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adhesive capsulitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bursitis frozen shoulder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adhesive capsulitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cairo university

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.